PlainRecalls
FDA Drug Moderate Class II Terminated

MIC-PLUS Injection, Vitamin Complex, MIC-COMBO* 25MG/50MG/50MG/1MG/20MG/5MG/ML INJECTABLE, For IM Use, Refrigerate, Protect From Light, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0231-3

Reported: March 11, 2020 Initiated: January 15, 2020 #D-0975-2020

Product Description

MIC-PLUS Injection, Vitamin Complex, MIC-COMBO* 25MG/50MG/50MG/1MG/20MG/5MG/ML INJECTABLE, For IM Use, Refrigerate, Protect From Light, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0231-3

Reason for Recall

Lack of Assurance of Sterility

Details

Units Affected
N/A
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic
Location
Los Angeles, CA

Frequently Asked Questions

What product was recalled?
MIC-PLUS Injection, Vitamin Complex, MIC-COMBO* 25MG/50MG/50MG/1MG/20MG/5MG/ML INJECTABLE, For IM Use, Refrigerate, Protect From Light, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0231-3. Recalled by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical. Units affected: N/A.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on March 11, 2020. Severity: Moderate. Recall number: D-0975-2020.